We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nutrien (NTR - Free Report) , a current Rank #5 (Strong Sell), is a leading integrated provider of crop inputs and services through its leading global retail network. Analysts have taken a bearish stance on the company’s outlook across the board.
Image Source: Zacks Investment Research
In addition, the company is in the Zacks Fertilizers industry, which is currently ranked in the bottom 14% of all Zacks industries. Let’s take a closer look at how the company currently stacks up.
Nutrien
Nutrien shares have faced a rocky road over the last year, down more than 20% and widely underperforming relative to the S&P 500. Quarterly results have consistently come in below expectations as of late, with NTR falling short of the Zacks Consensus EPS estimate by an average of 35% across its last four releases.
The less-than-ideal performance from shares has boosted its yield considerably, paying 4.2% on an annual basis.
Keep an eye out for the company’s upcoming quarterly release expected on May 8th, as current consensus expectations suggest a 67% pullback in earnings on 12% lower sales. Revenue expectations have been similarly taken lower, with the $5.4 billion expected down 1% since the beginning of February.
Image Source: Zacks Investment Research
Bottom Line
Analysts' negative earnings estimate revisions paint a challenging picture for the company’s shares in the near term.
Nutrien (NTR - Free Report) is a Zacks Rank #5 (Strong Sell), indicating that analysts have taken a bearish stance on the company’s earnings outlook.
For those seeking strong stocks, a great idea would be to focus on stocks carrying a Zacks Rank #1 (Strong Buy) or a Zacks Rank #2 (Buy). These stocks sport a notably stronger earnings outlook and the potential to deliver explosive gains in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bear of the Day: Nutrien (NTR)
Nutrien (NTR - Free Report) , a current Rank #5 (Strong Sell), is a leading integrated provider of crop inputs and services through its leading global retail network. Analysts have taken a bearish stance on the company’s outlook across the board.
Image Source: Zacks Investment Research
In addition, the company is in the Zacks Fertilizers industry, which is currently ranked in the bottom 14% of all Zacks industries. Let’s take a closer look at how the company currently stacks up.
Nutrien
Nutrien shares have faced a rocky road over the last year, down more than 20% and widely underperforming relative to the S&P 500. Quarterly results have consistently come in below expectations as of late, with NTR falling short of the Zacks Consensus EPS estimate by an average of 35% across its last four releases.
The less-than-ideal performance from shares has boosted its yield considerably, paying 4.2% on an annual basis.
Keep an eye out for the company’s upcoming quarterly release expected on May 8th, as current consensus expectations suggest a 67% pullback in earnings on 12% lower sales. Revenue expectations have been similarly taken lower, with the $5.4 billion expected down 1% since the beginning of February.
Image Source: Zacks Investment Research
Bottom Line
Analysts' negative earnings estimate revisions paint a challenging picture for the company’s shares in the near term.
Nutrien (NTR - Free Report) is a Zacks Rank #5 (Strong Sell), indicating that analysts have taken a bearish stance on the company’s earnings outlook.
For those seeking strong stocks, a great idea would be to focus on stocks carrying a Zacks Rank #1 (Strong Buy) or a Zacks Rank #2 (Buy). These stocks sport a notably stronger earnings outlook and the potential to deliver explosive gains in the near term.